Skip to Main Content

Author Details

Yoichi Sakurada
University of Yamanashi
2004
92
25
PMIDPaper TitleJournal TitlePublished Year
36729824DISTINCT CHARACTERISTICS OF SIMPLE VERSUS COMPLEX CENTRAL SEROUS CHORIORETINOPATHY.Retina2023
37289296Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy.Jpn J Ophthalmol2023
37111318A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result.Pharmaceuticals (Basel)2023
36477878Differentiating drusen and drusenoid deposits subtypes on multimodal imaging and risk of advanced age-related macular degeneration.Jpn J Ophthalmol2023
33355149Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome.Br J Ophthalmol2022
35732691Distinct characteristics of central serous chorioretinopathy according to gender.Sci Rep2022
36498654Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan.J Clin Med2022
36456827Genetic variants associated with glaucomatous visual field loss in primary open-angle glaucoma.Sci Rep2022
36482569Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report.Medicine (Baltimore)2022
36319691Characteristics of intermediate age-related macular degeneration with hyperreflective foci.Sci Rep2022
35304557Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment.Sci Rep2022
30289791DOCUMENTATION OF A NEW CHOROIDAL NEVUS.Retin Cases Brief Rep2021
33920794Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics.Int J Mol Sci2021
33807964Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity.J Clin Med2021
34956669Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications.J Ophthalmol2021
34572350Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy.Biomedicines2021
34678906The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation.Medicine (Baltimore)2021
34832882Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema.Pharmaceuticals (Basel)2021
34106635Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.Medicine (Baltimore)2021
34303031Long-term prognosis of polypoidal choroidal vasculopathy with a 5-year remission after an initial combination therapy.Photodiagnosis Photodyn Ther2021
33181763Reply.Retina2021
31348118RESOLUTION OF A SUBFOVEAL CHOROIDAL CAVERN AFTER HALF-DOSE PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY.Retin Cases Brief Rep2021
31415450RELATIONSHIP BETWEEN CHOROIDAL VASCULAR HYPERPERMEABILITY, CHORIOCAPILLARIS FLOW DENSITY, AND CHOROIDAL THICKNESS IN EYES WITH PACHYCHOROID PIGMENT EPITHELIOPATHY.Retina2020
37006516Cost and Outcomes Analysis of Polypoidal Choroidal Vasculopathy (Aneurysmal Type 1 Neovascularization) Treatment Strategies.J Vitreoretin Dis2020
31972795CUTICULAR DRUSEN: Risk of Geographic Atrophy and Macular Neovascularization.Retina2020
32092094Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.PLoS One2020
33437603Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year.Taiwan J Ophthalmol2020
32962278Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration.Pharmaceuticals (Basel)2020
32958214Genetics of primary open-angle glaucoma and its endophenotypes.Prog Brain Res2020
32780752Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results.PLoS One2020
32752023Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy.J Clin Med2020
32507953Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration.Int Ophthalmol2020
32346038Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Sci Rep2020
32160267Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.PLoS One2020
30629105Comparison of Ophthalmic Medication Prices Between the United States and Australia.JAMA Ophthalmol2019
31872073Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy.Commun Biol2019
31664630Clinical characteristics of cuticular drusen in the Japanese population.Jpn J Ophthalmol2019
31267312Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case.Jpn J Ophthalmol2019
31417165Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration.Sci Rep2019
30935655A Multinational Comparison of Anti-Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific.Ophthalmol Retina2019
28721823Genetic Risk Factors for Glaucoma and Exfoliation Syndrome Identified by Genome-wide Association Studies.Curr Neuropharmacol2018
29937127Multimodal Imaging to Monitor Recurrent Serpiginous Choroiditis.Ophthalmology2018
30198969ASSOCIATION BETWEEN CHOROIDAL CAVERNS AND CHOROIDAL VASCULAR HYPERPERMEABILITY IN EYES WITH PACHYCHOROID DISEASES.Retina2018
29844195<i>CFH</i> and <i>VIPR2</i> as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy.Proc Natl Acad Sci U S A2018
31047535Cuticular Drusen presenting with Subretinal Drusenoid Deposits (Pseudodrusen).Ophthalmol Retina2018
30480742Genome-Wide Association Study to Identify a New Susceptibility Locus for Central Serous Chorioretinopathy in the Japanese Population.Invest Ophthalmol Vis Sci2018
29470970Comparisons Between Histology and Optical Coherence Tomography Angiography of the Periarterial Capillary-Free Zone.Am J Ophthalmol2018
29566865Multimodal Imaging in Adult-Onset Coats' Disease.Ophthalmology2018
29177890AREDS simplified severity scale as a predictive factor for response to aflibercept therapy for typical neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol2018
29045945Retreatment of Exudative Age-Related Macular Degeneration after Loading 3-Monthly Intravitreal Ranibizumab.Ophthalmologica2018
  • 1 - 50 of 92

Recommended Authors

Sarra Gattoussi
LuEsther T. Mertz Retinal Research Center and Manhattan Eye, and Throat Hospital
Career Start Year 2017
Number of shared co-authors 6
Jin Yang
Tianjin Eye Hospital & Eye Institute, Nankai University
Career Start Year 2016
Number of shared co-authors 1
Ming Zhang
West China Hospital, Sichuan University
Career Start Year 2008
Number of shared co-authors 4
Kelvin Yi Chong Teo
Singapore Eye Research Institute
Career Start Year 2007
Number of shared co-authors 9
Daniela Ferrara
Tufts Medical Center, Tufts University School of Medicine
Career Start Year 2007
Number of shared co-authors 10
Shyamanga Borooah
Shiley Eye Institute, University of California
Career Start Year 2007
Number of shared co-authors 2
Daniel Barthelmes
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 7
Roy Schwartz
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2006
Number of shared co-authors 6
Meixia Zhang
West China Hospital, Sichuan University
Career Start Year 2006
Number of shared co-authors 0
Eleonora M Lad
Duke University Medical Center
Career Start Year 2002
Number of shared co-authors 3
Jayashree Sahni
Novartis Pharma AG
Career Start Year 2001
Number of shared co-authors 6
Milam A Brantley
University of Cambridge
Career Start Year 2000
Number of shared co-authors 4
Nicolas Leveziel
Universite de Poitiers, INSERM 4 Department of Ophthalmology
Career Start Year 2000
Number of shared co-authors 2
Peter Charbel Issa
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust
Career Start Year 2000
Number of shared co-authors 4
Sobha Sivaprasad
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Career Start Year 1999
Number of shared co-authors 12
Glenn Yiu
University of California davis
Career Start Year 1998
Number of shared co-authors 2
Yoon Jeon Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1996
Number of shared co-authors 0
Adnan Tufail
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 11
Andrew J Lotery
University of Southampton
Career Start Year 1994
Number of shared co-authors 10
Eric H Souied
University of Paris Est-Creteil
Career Start Year 1994
Number of shared co-authors 15
Lucia Sobrin
Massachusetts Eye and Ear Infirmary
Career Start Year 1994
Number of shared co-authors 7
Allen C Ho
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 10
Quan Dong Nguyen
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 3
Robyn H Guymer
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Career Start Year 1989
Number of shared co-authors 12
Giovanni Staurenghi
Eye Clinic, Department of Biomedical and Clinical Science, University of Milan
Career Start Year 1987
Number of shared co-authors 14
Frank G Holz
University of Bonn
Career Start Year 1987
Number of shared co-authors 13
Usha Chakravarthy
Queen's University Belfast
Career Start Year 1985
Number of shared co-authors 14
Emily Y Chew
National Eye Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 12
Philip J Rosenfeld
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1981
Number of shared co-authors 13
Michael L Klein
Casey Eye Institute, Oregon Health & Science University
Career Start Year 1974
Number of shared co-authors 6

Collaborators

Kenneth Bailey Freund
NYU Grossman School of Medicine
Co-authored papers 9
Tien Yin Wong
Tsinghua University
Co-authored papers 6
Chiea Chuen Khor
Co-authored papers 5
Ching-Yu Cheng
Singapore Eye Research Institute, Singapore Duke-NUS Medical School
Co-authored papers 4
Yasha S Modi
New York University School of Medicine, New York University Langone Health
Co-authored papers 4
Tin Aung
Co-authored papers 3
Zhenglin Yang
The University of Texas at Austin
Co-authored papers 3
Eranga N Vithana
Co-authored papers 3
Chui Ming Gemmy Cheung
Singapore Eye Research Institute
Co-authored papers 3
Chandrakumar Balaratnasingam
Lions Eye Institute
Co-authored papers 3
Orly Gal-Or
Rabin Medical Center, Tel Aviv University
Co-authored papers 3
E-Shyong Tai
Co-authored papers 2
Yechiel Friedlander
Co-authored papers 2
Jianjun Liu
Co-authored papers 2
Ningli Wang
Beijing Tongren Hospital, Capital Medical University
Co-authored papers 2
Martin L Hibberd
London School of Hygiene and Tropical Medicine
Co-authored papers 2
Yik-Ying Teo
Co-authored papers 2
Peng Chen
Co-authored papers 2
Rob M van Dam
Co-authored papers 2
Ji Eun Lee
Soonchunhyang University College of Medicine, Bucheon Hospital
Co-authored papers 2
Jay Chhablani
University of Pittsburgh
Co-authored papers 2
Gavin S W Tan
Singapore Eye Research Institute
Co-authored papers 2
Dong An
The University of Western Australia, Australia Lions Eye Institute
Co-authored papers 1
Nitish Mehta
New York University Department of Ophthalmology
Co-authored papers 1
SriniVas R Sadda
Doheny Eye Institute, University of California Los Angeles
Co-authored papers 1
David Sarraf
Stein Eye Institute, University of California Los Angeles
Co-authored papers 1
Carel B Hoyng
Radboud University Medical Center
Co-authored papers 1
Jing Cheng
Co-authored papers 1
Ian L McAllister
University of Western Australia, Lions Eye Institute
Co-authored papers 1
Aaron Lee
Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis
Co-authored papers 1
Release 1.2